ArsenalBio Secures $325M with Regeneron, BMS Backing
ArsenalBio raises $325M to advance solid tumor CAR-T therapies. Focus on kidney, prostate cancer with innovative genomic technology.
- Latest
- Trending
ArsenalBio raises $325M to advance solid tumor CAR-T therapies. Focus on kidney, prostate cancer with innovative genomic technology.
Beam Therapeutics leads with CRISPR in treating genetic diseases, opening new market avenues.
Researchers have successfully developed a single-dose vaccine that prompts the production of T-cells and "memory" B cells to fight against ...
New technologies are revolutionizing deep-sea research, allowing for rapid exploration and identification of fragile organisms in minutes. #DeepSeaResearch #MarineExploration #NewTechnologies
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.